Scholars Central

Research articlePublished 2018

Use of Systemic Immuno-Modulatory Medications in Children with Atopic Dermatitis

Authors: Schneeweiss MC, Solomon DH, Merola JF

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: Immuno-modulatory agents are increasingly discussed for the treatment of atopic dermatitis (AD) in children. We sought to understand patterns of systemic immuno-modulatory medication uses in children. Methods: We used longitudinal patient data from an insurance claims database, IBM Market Scan, covering 185 million patients in the US between 2003 and 2016 to identify children with a diagnosis of AD (ICD-9 691.x or ICD-10 L20.9) associated with an outpatient or inpatient encounter. We computed the proportion of patients using systemic medications for the treatment of AD during the 6 months following the first office visit with a diagnosis of AD. Medications of interest include systemic non-biologic immuno-modulatory drugs and biologic immunomodulatory drugs. We trended the use of systemic immuno-modulatory agents for the treatment of pediatric AD over a 10-year period, from 2005-2015, including for each agent separately. Results: We identified 1.6 million children with AD and no other auto-immune or inflammatory conditions that would otherwise require immune-modulatory treatment. Across all age groups the use of biologic agents increased from 0.1 to 0.3 per 1,000 over the 10-year period from 2005-2015 and the use of non-biologic systemic immunomodulatory drugs increased from 0.2 to 0.7 per 1,000. Among the non-biologic systemic agents’ methotrexate was the one increasing fastest (0.1 to 0.3). Conclusion: In children and adolescents diagnosed with atopic dermatitis and without other disease indication for their use, the new use of systemic immuno-modulatory agents was infrequent but steadily increasing over the past 10 years.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pediatric Dermatology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pediatric Dermatology
  • SubjectDermatology
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Schneeweiss MC”
  • BylineArticles whose byline prints “Solomon DH”
  • BylineArticles whose byline prints “Merola JF”